对碳青霉烯耐药大肠埃希菌引起的复杂性尿路感染进行替加环素治疗后出现耐替加环素肺炎克雷伯菌。 - Suppr

Suppr

超能文献

Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli.

作者信息

Tsai Hsih-Yeh, Liao Chun-Hsing, Cheng Aristine, Liu Chia-Ying, Huang Yu-Tsung, Sheng Wang-Huei, Hsueh Po-Ren

出版信息

J Infect. 2012 Dec;65(6):584-6. doi: 10.1016/j.jinf.2012.09.007. Epub 2012 Sep 19.

DOI:10.1016/j.jinf.2012.09.007

PMID:23000236

Abstract

摘要

相似文献

Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli.对碳青霉烯耐药大肠埃希菌引起的复杂性尿路感染进行替加环素治疗后出现耐替加环素肺炎克雷伯菌。

J Infect. 2012 Dec;65(6):584-6. doi: 10.1016/j.jinf.2012.09.007. Epub 2012 Sep 19.

Emergence of tigecycline resistance amongst multi-drug resistant gram negative isolates in a multi-disciplinary hospital.一家多学科医院中多重耐药革兰氏阴性菌分离株对替加环素耐药性的出现。

J Infect. 2010 Oct;61(4):358-9. doi: 10.1016/j.jinf.2010.07.012. Epub 2010 Jul 27.

Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial.美国肠杆菌科细菌多重耐药性的区域差异及新型甘氨酰环素类抗菌药物替加环素的比较活性

Int J Antimicrob Agents. 2007 May;29(5):518-27. doi: 10.1016/j.ijantimicag.2006.10.019. Epub 2007 Mar 21.

In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital.替加环素对比利时一家医院分离出的耐多药肠杆菌科细菌的体外活性。

Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):381-4. doi: 10.1007/s10096-008-0629-9. Epub 2008 Sep 19.

In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.依拉环素对耐碳青霉烯类肠杆菌科细菌和鲍曼不动杆菌的体外活性

Antimicrob Agents Chemother. 2016 May 23;60(6):3840-4. doi: 10.1128/AAC.00436-16. Print 2016 Jun.

Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.替加环素针对包括耐四环素分离株在内的全球肠杆菌科菌株集合的活性测试。

Diagn Microbiol Infect Dis. 2005 Jul;52(3):209-13. doi: 10.1016/j.diagmicrobio.2005.06.010.

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.针对碳青霉烯类耐药肠杆菌科细菌，还有哪些选择？氯霉素、环丙沙星、黏菌素、磷霉素、米诺环素、呋喃妥因、替莫西林和替加环素的评估。

Int J Antimicrob Agents. 2011 May;37(5):415-9. doi: 10.1016/j.ijantimicag.2011.01.012. Epub 2011 Mar 22.

Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).针对来自18个欧洲国家的耐碳青霉烯类肠杆菌科细菌的替加环素活性检测：哨兵监测项目（2010 - 2013年）的结果

Diagn Microbiol Infect Dis. 2015 Oct;83(2):183-6. doi: 10.1016/j.diagmicrobio.2015.06.011. Epub 2015 Jun 23.

Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae.台湾地区针对替加环素对产超广谱β-内酰胺酶肠杆菌科临床分离株的体外活性开展的全国性监测。

Int J Antimicrob Agents. 2008 Nov;32 Suppl 3:S179-83. doi: 10.1016/S0924-8579(08)70024-4.

Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.替加环素单独及联合黏菌素和美罗培南对产碳青霉烯酶肠杆菌科细菌（KPC）菌株的时间杀菌试验研究。

Int J Antimicrob Agents. 2011 Mar;37(3):244-7. doi: 10.1016/j.ijantimicag.2010.10.031. Epub 2011 Jan 13.

引用本文的文献

Role of tigecycline in the treatment of urinary tract infections: a systematic review of published case reports.替加环素在治疗尿路感染中的作用：对已发表病例报告的系统评价

Infez Med. 2022 Dec 1;30(4):516-524. doi: 10.53854/liim-3004-5. eCollection 2022.

Role of Tigecycline for the Treatment of Urinary Tract Infections.替加环素在治疗尿路感染中的作用。

J Pharm Technol. 2014 Jun;30(3):87-92. doi: 10.1177/8755122513519332. Epub 2014 Jan 7.

Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.多黏菌素 B 和替加环素联合克服耐碳青霉烯类肺炎克雷伯菌异质性耐药的效果。

Microbiol Spectr. 2021 Oct 31;9(2):e0015221. doi: 10.1128/Spectrum.00152-21. Epub 2021 Oct 27.

Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review.替加环素治疗复杂性尿路感染的疗效与安全性：一项系统评价

Transl Androl Urol. 2021 Jan;10(1):292-299. doi: 10.21037/tau-20-959.

Emergence of tigecycline resistance in co-producing MCR-1 and NDM-5 during tigecycline salvage treatment.替加环素挽救治疗期间同时产生MCR-1和NDM-5的替加环素耐药性的出现。

Infect Drug Resist. 2018 Nov 13;11:2241-2248. doi: 10.2147/IDR.S179618. eCollection 2018.

Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae.OqxAB 和 MacAB 外排泵的过度表达导致肺炎克雷伯菌临床分离株对依拉环素的耐药性和异质性耐药。

Emerg Microbes Infect. 2018 Aug 1;7(1):139. doi: 10.1038/s41426-018-0141-y.

Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.替加环素敏感性及外排泵在产KPC肺炎克雷伯菌对替加环素耐药中的作用

PLoS One. 2015 Mar 3;10(3):e0119064. doi: 10.1371/journal.pone.0119064. eCollection 2015.

Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniae bacteremia in Taiwan.台湾地区替加环素不敏感肺炎克雷伯菌菌血症的临床和微生物学特征。

BMC Infect Dis. 2014 Jan 1;14:1. doi: 10.1186/1471-2334-14-1.

Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae.多药耐药肺炎克雷伯菌替加环素耐药性产生的巢式病例对照研究。

Antimicrob Agents Chemother. 2013 Nov;57(11):5743-6. doi: 10.1128/AAC.00827-13. Epub 2013 Aug 26.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验